Stock Earnings

Question 1

What are BioInvent International AB (publ)'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), BioInvent International AB (publ) has a total asset of $671, Net loss of $-332

Question 2

What are the key financial ratios for BOVNF?

Accepted Answer

BioInvent International AB (publ)'s Current ratio is 5.93, has a Net margin is -146.9, sales per share of $3.43.

Question 3

How is BioInvent International AB (publ)'s revenue broken down by segment or geography?

Accepted Answer

BioInvent International AB (publ) largest revenue segment is Pharmaceutical, at a revenue of 44,686,000 in the most earnings release.For geography, United States is the primary market for BioInvent International AB (publ), at a revenue of 36,822,000.

Question 4

Is BioInvent International AB (publ) profitable?

Accepted Answer

no, according to the latest financial statements, BioInvent International AB (publ) has a net loss of $-332

Question 5

Does BioInvent International AB (publ) have any liabilities?

Accepted Answer

yes, BioInvent International AB (publ) has liability of 113

Question 6

How many outstanding shares for BioInvent International AB (publ)?

Accepted Answer

BioInvent International AB (publ) has a total outstanding shares of 65.8

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	226	226	44	71	326	19
Revenue Growth (YoY)	413.99%	413.99%	-38%	-78%	1,616%	-87%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	73	73	56	50	49	38
Research & Development	504	504	439	374	312	244
Operating Expenses	578	578	515	442	376	297
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-332	-332	-429	-330	-42	-278
Income Tax Expense	0	0	0	0	0	0
Net Income	-332	-332	-429	-330	-42	-278
Net Income Growth	-22%	-23%	30%	686%	-85%	266%
Shares Outstanding (Diluted)	65.86	65.78	65.8	65.76	61.52	54.16
Shares Change (YoY)	0%	0%	0%	7%	14%	89%
EPS (Diluted)	-5.05	-5.06	-6.52	-5.02	-0.69	-5.14
EPS Growth	-23%	-22%	30%	627%	-87%	93%
Free Cash Flow	-257	-257	-390	-351	-52	-259
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-155.3%	-155.3%	-1,070.45%	-521.12%	-15.33%	-1,463.15%
Profit Margin	-146.9%	-146.9%	-975%	-464.78%	-12.88%	-1,463.15%
Free Cash Flow Margin	-113.71%	-113.71%	-886.36%	-494.36%	-15.95%	-1,363.15%
EBITDA	-332	-332	-452	-354	-36	-264
EBITDA Margin	-146.9%	-146.9%	-1,027.27%	-498.59%	-11.04%	-1,389.47%
D&A For EBITDA	19	19	19	16	14	14
EBIT	-351	-351	-471	-370	-50	-278
EBIT Margin	-155.3%	-155.3%	-1,070.45%	-521.12%	-15.33%	-1,463.15%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

BioInvent International AB (publ) (BOVNF) Financial

BOVNF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BIOINVENT INTERNATIONAL AB?

BOVNF Income

Follow-Up Questions